Dr. Gil has had a 30+ year career in Pharmaceutical R&D. He is currently CEO of Pelage Pharmaceuticals, which is developing a topical hair growth treatment. As VP, Research Technologies and Portfolio at Allergan, he served as co-chair of the Early Stage Governance Board that oversaw preclinical to early phase 2 clinical development, chaired the…
For the past eight years, as a Principal and CFO at Visionary, Garrett E. Hamontree has helped develop Visionary Venture Fund into the most active investor in the Ophthalmology space. Mr. Hamontree is responsible for due diligence of potential investments with a focus on valuations and market potential, assisting in negotiating and executing transactions, as…

Jeffry Weinhuff is the founder and Managing Partner / Chief Investment Officer of Visionary Venture Fund, one of the most active investors in the eye for both pharmaceuticals and medical devices. Visionary’s unique model of partnering with 90 Key Opinion Leader Eye Care Professionals provides unique insights into clinical benefits of emerging companies as well…

